MktsMarkets

vTv Therapeutics Inc.
NASDAQ: VTVTKey statistics
VTVT News
Stories mentioning VTVT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 36,839 | 0.00 | 0.00 | 0.00 | 0.00 | 17.00 | 0.00 | 0.00 |
| Cost of Goods Sold | ||||||||
| Gross Profit | ||||||||
| Operating Expenses | ||||||||
| Research & Development | 8,978 | 3,908 | 7,020 | 4,103 | 2,830 | 2,234 | 3,224 | 3,439 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 13,576 | 7,885 | 10,699 | 7,721 | 6,503 | 4,909 | 6,506 | 7,155 |
| Operating Income (Loss) | 23,263 | (7,885) | (10,699) | (7,721) | (6,503) | (4,892) | (6,506) | (7,155) |
| Interest Income | 838.00 | 865.00 | 399.00 | 275.00 | 331.00 | 429.00 | 504.00 | 553.00 |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 24,134 | (7,138) | (10,345) | (7,380) | (6,217) | (4,437) | (5,840) | (6,409) |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income (Loss) | 24,134 | (7,138) | (8,698) | (6,046) | (5,092) | (3,634) | (4,783) | (5,180) |
| Earnings Per Share (Basic) | ||||||||
| Earnings Per Share (Diluted) | ||||||||
| Weighted Average Shares Outstanding (Basic) | ||||||||
| Weighted Average Shares Outstanding (Diluted) | ||||||||
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VTVT
vTv Therapeutics Inc. (NASDAQ: VTVT) is a stock listed on the Nasdaq Stock Market under the ticker symbol VTVT. It last traded at $22.11 (Nov 5, 2026, 9:30 AM ET), down 8.0% on the day. That gives vTv Therapeutics a market capitalisation of $106.6M.
Over the past 52 weeks VTVT has traded between $21.73 and $44.00.
Revenue for the quarter ended Mar 31, 2026 was $36.8M; net income $24.1M.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $36.8M | $24.1M | 65.5% |
| Dec 31, 2025 | $0 | -$7.1M | — |
| Sep 30, 2025 | $0 | -$8.7M | — |
| Jun 30, 2025 | $0 | -$6.0M | — |
From vTv Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…